S-1

Company

Oncotelic Therapeutics, Inc.

Filed

May 11, 2017

Accession Number

0001193125-17-167444

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →